These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 2483443)

  • 21. Double-blind placebo-controlled study of ibopamine and digoxin in patients with mild to moderate heart failure: results of the Dutch Ibopamine Multicenter Trial (DIMT).
    van Veldhuisen DJ; Man in 't Veld AJ; Dunselman PH; Lok DJ; Dohmen HJ; Poortermans JC; Withagen AJ; Pasteuning WH; Brouwer J; Lie KI
    J Am Coll Cardiol; 1993 Nov; 22(6):1564-73. PubMed ID: 7901256
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluation of acute hemodynamic effects and pharmacokinetic behaviour of ibopamine in patients with severe heart failure.
    De Vita C; Triulzi E; Devizzi S; Colombo G; Palvarini M; Pocchiari F; Pataccini R
    Arzneimittelforschung; 1986 Feb; 36(2A):349-54. PubMed ID: 3707648
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The effects of ibopamine on glomerular filtration rate and plasma norepinephrine remain preserved during prolonged treatment in patients with congestive heart failure.
    Lieverse AG; Girbes AR; Van Veldhuisen DJ; Smit AJ; Zijlstra JG; Meijer S; Lie KI; Reitsma WD
    Eur Heart J; 1995 Jul; 16(7):937-42. PubMed ID: 7498209
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dopaminergic inhibition of metoclopramide-induced aldosterone secretion in man. Dissociation of responses to dopamine and bromocriptine.
    Carey RM; Thorner MO; Ortt EM
    J Clin Invest; 1980 Jul; 66(1):10-8. PubMed ID: 7400305
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hemodynamic evaluation during exercise test after acute and chronic ibopamine treatment in patients with congestive heart failure.
    Gavazzi A; Mussini A; Bramucci E
    Arzneimittelforschung; 1986 Feb; 36(2A):366-70. PubMed ID: 3707652
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Preliminary evaluation of the effect of ibopamine on the secretion of prolactin].
    Scarazzati E; Catenazzo G; Melloni CF; Ghirardi P; Bianco L
    Boll Soc Ital Biol Sper; 1983 Nov; 59(11):1631-5. PubMed ID: 6667307
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Monitored long-term treatment with ibopamine in patients suffering from severe congestive heart failure.
    Avanzini Z; Bellogini GC; Brusoni B; Ciampani N; Dei Cas L; Gazzola U; Maggi GC; Mangiavacchi M; Metra M; Pinca L
    Arzneimittelforschung; 1986 Feb; 36(2A):394-7. PubMed ID: 3707656
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [The influence of ACE inhibitors on urinary electrolyte secretion and the response to transitory hypovolemia in chronic heart failure].
    Marenzi G; Lauri G; Assanelli E; Grazi M; Guazzi M; Berna G; Salvioni A; Agostoni P
    Cardiologia; 1997 Dec; 42(12):1277-83. PubMed ID: 9534323
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ibopamine: long-term safety study in patients with congestive heart failure. The Italian Ibopamine Working Group.
    Riva E; Cavalli A; Abbondati G; Cedrini MC; Schleman M; Fuccella LM
    Int J Clin Pharmacol Res; 1989; 9(1):21-8. PubMed ID: 2707922
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [The renin-angiotensin-aldosterone system and antidiuretic hormone in chronic circulatory failure in elderly subjects].
    Khaĭdarova GKh
    Ter Arkh; 1992; 64(3):109-11. PubMed ID: 1440254
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Long-term therapy of chronic congestive heart failure with ibopamine: a multicenter trial.
    Rolandi E; Sabino F; Cantoni V; Ghirardi P; Marchetti GV; Cicchetti V
    J Cardiovasc Pharmacol; 1989; 14 Suppl 8():S93-103. PubMed ID: 2483446
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of digoxin, placebo and ibopamine on exercise tolerance and cardiac rhythm of patients with chronic post-infarct left ventricular failure.
    Cadel A; Brusoni B; Pirelli P; Osculati G; Rovati A; Fanciulli R; Carati L; Valagussa F
    Arzneimittelforschung; 1986 Feb; 36(2A):376-9. PubMed ID: 3707653
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Positive inotropic effects of ibopamine in patients with congestive heart failure. A multicenter investigation.
    Caponnetto S; Allegro A; Bellotti G; Cataldi A; Salvemini M; Portioli I; Prati PL; Gambelli G; Boccanelli A; Zacharo E
    Arzneimittelforschung; 1986 Feb; 36(2A):386-90. PubMed ID: 3518725
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [New dopamine agonists in cardiovascular therapy].
    Girbes AR; Van Veldhuisen DJ; Smit AJ
    Presse Med; 1992 Aug 29-Sep 5; 21(27):1287-91. PubMed ID: 1359528
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dopamine control of aldosterone secretion in end-stage renal failure.
    García-Robles R; Ruilope L; Tovar J; de Villa LF; Miranda B; Prieto C; Parada J; Sancho J; Rodicio JL
    Rev Esp Fisiol; 1986 Jun; 42(2):257-63. PubMed ID: 3092288
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pharmacological profile of ibopamine. A summary of experiments on anaesthesized dogs.
    Marchetti GV
    Cardiology; 1990; 77 Suppl 5():22-9. PubMed ID: 1980631
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cardiovascular and renal action of dopaminergic prodrugs.
    Casagrande C; Merlo L; Ferrini R; Miragoli G; Semeraro C
    J Cardiovasc Pharmacol; 1989; 14 Suppl 8():S40-59. PubMed ID: 2483441
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hemodynamic and neurohumoral effects of ibopamine in patients with chronic congestive heart failure.
    López-Sendón J
    Cardiology; 1990; 77 Suppl 5():9-21. PubMed ID: 1980634
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inhibition of the aldosterone response to sodium depletion in man by stimulation of dopamine DA2 receptors.
    Lombardi C; Missale C; De Cotiis R; Spedini C; Pizzoccolo G; Memo M; Albertini A; Spano PF
    Eur J Clin Pharmacol; 1988; 35(3):323-6. PubMed ID: 2972550
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Dopamine and dopaminergic drugs as therapeutic agents in heart failure].
    van Zwieten PA
    Ned Tijdschr Geneeskd; 1990 Nov; 134(47):2281-4. PubMed ID: 1979426
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.